Management of Cardiac Arrest in Intubated Sickle Cell Patient with Active Acute Chest Syndrome
Initiate standard ACLS protocols immediately, and if return of spontaneous circulation (ROSC) is achieved, strongly consider urgent red cell exchange (RCE) transfusion—preferably automated RCE—to rapidly reduce HbS levels and address the underlying acute chest syndrome that likely precipitated the arrest.
Immediate Resuscitation Phase
Standard ACLS Protocol
- Follow standard Advanced Cardiac Life Support (ACLS) guidelines for cardiac arrest management regardless of the underlying sickle cell disease 1
- Continue high-quality chest compressions and appropriate rhythm-specific interventions 1
- The patient is already intubated, which addresses airway management 1
Consider ECMO for Refractory Arrest
- If standard ACLS fails and the patient remains in cardiac arrest, extracorporeal membrane oxygenation (ECMO) should be strongly considered as a rescue strategy for this life-threatening situation 2, 3
- Venovenous (VV) ECMO has been successfully used in pediatric patients with sickle cell disease and life-threatening acute chest syndrome, with 85% survival in the ELSO registry 3
- Venoarterial (VA) ECMO can be used for cardiogenic shock/cardiac dysfunction in sickle cell patients, though with lower survival (43%) and higher complication rates including cerebrovascular accidents 3
- The decision between VV and VA ECMO depends on whether the arrest is primarily respiratory failure versus cardiogenic shock 3
Post-ROSC Management
Aggressive Transfusion Therapy
Once ROSC is achieved, immediately consult hematology for urgent red cell exchange transfusion 4
- Automated RCE is preferred over manual RCE or simple transfusion in patients with severe acute chest syndrome to more rapidly reduce HbS levels 4
- The American Society of Hematology 2020 guidelines specifically recommend automated RCE or manual RCE over simple transfusions for severe acute chest syndrome 4
- This patient with cardiac arrest in the setting of acute chest syndrome represents the most severe end of the spectrum and warrants the most aggressive transfusion approach 4
Critical Considerations for RCE
- Special equipment and trained staff are needed for automated RCE 4
- Pre- and post-procedure complete blood count and hemoglobin fractionation should be obtained 4
- If the patient has small total blood volume, a red cell prime may be required due to extracorporeal volume of the apheresis machine 4
Post-Cardiac Arrest Care
- Follow standard post-cardiac arrest care protocols per 2025 AHA guidelines, including targeted temperature management and neuroprognostication 1
- Be aware that mechanical circulatory support (MCS) devices beyond ECMO (such as Impella or intra-aortic balloon pump) have not shown survival benefit in routine use for post-cardiac arrest cardiogenic shock and carry increased bleeding and vascular complications 1
- Selective use of MCS may be considered for refractory cardiogenic shock in non-comatose patients 1
Common Pitfalls and Complications
ECMO-Related Complications in Sickle Cell Patients
- Sickle cell patients on ECMO have unique risks: 10% of those receiving VA ECMO experienced cerebral infarct or hemorrhage 3
- Significant bleeding, neurological injury, and kidney injury can occur with both VV and VA ECMO 3
- Despite these risks, ECMO remains a viable rescue option with 52% overall survival in pediatric sickle cell patients in the ELSO registry 3
Transfusion Considerations
- Patients with rapidly progressive acute chest syndrome who do not respond to initial treatment require escalation to RCE 4
- High pretransfusion hemoglobin levels that preclude simple transfusion are another indication for RCE 4
- Phenotypically matched transfusions should be used when possible to minimize alloimmunization risk 5